Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

1737 ARTÍCULOS , VIENDO DEL 826 AL 840

Treatment of Sleep Dysfunction in Parkinson's Disease

Amara AW, Chahine LM, Videnovic A.

Curr Treat Options Neurol. 2017 Jul;19(7):26. doi: 10.1007/s11940-017-0461-6.

Dopaminergic Therapies for Non-motor Symptoms in Parkinson's Disease

Schaeffer E, Berg D.

CNS Drugs. 2017 Jul;31(7):551-570. doi: 10.1007/s40263-017-0450-z.

Ferric carboxymaltose in patients with restless legs syndrome and nonanemic iron deficiency: A randomized trial

Trenkwalder C, Winkelmann J, Oertel W, Virgin G, Roubert B, Mezzacasa A; FCM-RLS Study Investigators.

Mov Disord. 2017 Oct;32(10):1478-1482. doi: 10.1002/mds.27040. Epub 2017 Jun 23.

Comorbid Sleep Disturbances in Neurologic Disorders

Ju YS, Videnovic A, Vaughn BV.

Continuum (Minneap Minn). 2017 Aug;23(4, Sleep Neurology):1117-1131. doi: 10.1212/CON.0000000000000501.

Sleep Dysfunction in Parkinson's Disease

Falup-Pecurariu C, Diaconu Ş.

Int Rev Neurobiol. 2017;133:719-742. doi: 10.1016/bs.irn.2017.05.033. Epub 2017 Jul 10.

Characterizing restless legs syndrome and leg motor restlessness in patients with Parkinson's disease: A multicenter case-controlled study

Suzuki K, Okuma Y, Uchiyama T, Miyamoto M, Sakakibara R, Shimo Y, Hattori N, Kuwabara S, Yamamoto T, Kaji Y, Hirano S, Numao A, Hirata K; Kanto NMPD investigators.

Parkinsonism Relat Disord. 2017 Nov;44:18-22. doi: 10.1016/j.parkreldis.2017.08.007. Epub 2017 Aug 14.

Impact of sleep-related symptoms on clinical motor subtypes and disability in Parkinson's disease: a multicentre cross-sectional study

Suzuki K, Okuma Y, Uchiyama T, Miyamoto M, Sakakibara R, Shimo Y, Hattori N, Kuwabara S, Yamamoto T, Kaji Y, Hirano S, Kadowaki T, Hirata K; Kanto NMPD investigators.

J Neurol Neurosurg Psychiatry. 2017 Nov;88(11):953-959. doi: 10.1136/jnnp-2017-316136. Epub 2017 Aug 28.

Rotigotine transdermal patch and sleep in Parkinson's disease: where are we now?

Rosa-Grilo M, Qamar MA, Taddei RN, Pagonabarraga J, Kulisevsky J, Sauerbier A, Chaudhuri KR.

NPJ Parkinsons Dis. 2017 Sep 5;3:28. doi: 10.1038/s41531-017-0030-4. eCollection 2017.

Parasomnias and Sleep-Related Movement Disorders in Older Adults

Iranzo A.

Sleep Med Clin. 2018 Mar;13(1):51-61. doi: 10.1016/j.jsmc.2017.09.005. Epub 2017 Nov 15.

Neurodegenerative Disorders and Sleep

Malhotra RK.

Sleep Med Clin. 2018 Mar;13(1):63-70. doi: 10.1016/j.jsmc.2017.09.006. Epub 2017 Nov 10.

Restless Legs Syndrome and Sleep-Related Movement Disorders

Trotti LM.

Continuum (Minneap Minn). 2017 Aug;23(4, Sleep Neurology):1005-1016. doi: 10.1212/CON.0000000000000488.

[Genetic risk variants in Parkinson's disease and other movement disorders]

Brockmann K, Lohmann K.

Nervenarzt. 2017 Jul;88(7):713-719. doi: 10.1007/s00115-017-0348-5.

An update on new and unique uses of botulinum toxin in movement disorders

Jankovic J.

Toxicon. 2018 Jun 1;147:84-88. doi: 10.1016/j.toxicon.2017.09.003. Epub 2017 Sep 6.

Movement Disorders in Women

Baker JM, Hung AY.

Semin Neurol. 2017 Dec;37(6):653-660. doi: 10.1055/s-0037-1608845. Epub 2017 Dec 21.

Pramipexole Overdose Associated with Visual Hallucinations, Agitation and Myoclonus

Cardon-Dunbar A, Robertson T, Roberts MS, Isbister GK.

J Med Toxicol. 2017 Dec;13(4):343-346. doi: 10.1007/s13181-017-0615-7. Epub 2017 May 25.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias